About Us
Brands in Conversation
Academic Connect
Marketing Trailblazers
Marketers in Conversation
Marketing Guru Speaks
Case Studies
Contact Us
Contribute Articles
Market Intelligence & Research
Skilling Programs
Internship
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Sunday, October 4, 2026
Sign in / Join
Home
Disclaimer
Facebook
Instagram
Linkedin
X
WhatsApp
About Us
Brands in Conversation
Academic Connect
Marketing Trailblazers
Marketers in Conversation
Marketing Guru Speaks
Case Studies
Contact Us
Contribute Articles
Market Intelligence & Research
Skilling Programs
Internship
Search
Home
Tags
Alembic Pharmaceuticals
Tag: Alembic Pharmaceuticals
Brands in Conversation
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Prucalopride Tablets
Author
-
July 29, 2026
0
Brands in Conversation
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Dapsone Gel, 5%
Author
-
June 29, 2026
0
Brands in Conversation
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Oseltamivir Phosphate for Oral Suspension
Author
-
June 26, 2026
0
Marketers in Conversation
Alembic Pharmaceuticals Appoints Mr. Ramesh Juneja as Executive Vice President – Human Health (Sales and Marketing), India Business
Author
-
June 2, 2026
0
Brands in Conversation
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Levothyroxine Sodium Tablets
Author
-
May 22, 2026
0
Brands in Conversation
Alembic Pharmaceuticals Partners with Enthral.ai for Learning and Training Management of its 9000+ learners
Author
-
April 2, 2026
0
Brands in Conversation
Alembic Pharmaceuticals and Amlan International launch MinerTox-Z and MinerTox-A
Author
-
October 8, 2025
0
Brands in Conversation
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets
Passionate in Marketing
-
August 19, 2025
0
Brands in Conversation
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Extended-Release Tablets.
Author
-
July 28, 2025
0
Brands in Conversation
Alembic Pharmaceuticals acquires Utility Therapeutics for $12 million to strengthen U.S. footprint
Author
-
July 3, 2025
0
1
2
Page 1 of 2